164
Participants
Start Date
October 11, 2022
Primary Completion Date
March 30, 2026
Study Completion Date
March 30, 2026
IGC-AD1-Active
A non-sterile solution for oral administration.
IGC-AD1-Placebo
A non-sterile solution for oral administration similar in color and texture to the Active.
RECRUITING
Ichor Research, Syracuse
RECRUITING
Medstar Georgetown University Hospital Neurology, Clinton
RECRUITING
Medstar Montgomery Medical Center, Olney
RECRUITING
MedStar Franklin Square Medical Center Neurology, Baltimore
RECRUITING
Dominion Medical Associates, Inc., Richmond
ACTIVE_NOT_RECRUITING
ClinCloud, LLC, Maitland
RECRUITING
ClinCloud, LLC, Melbourne
RECRUITING
Global Medical Institutes Florida, LLC, Miami
RECRUITING
Miami Jewish Health, Miami
RECRUITING
University of South Florida Department of Psychiatry and Behavioral Neurosciences, Tampa
RECRUITING
BayCare Health System Inc., St. Petersburg
RECRUITING
Neurostudies Inc., Port Charlotte
NOT_YET_RECRUITING
Tandem Intermediate, LLC, Metairie
RECRUITING
Tekton Research LLC, Yukon
RECRUITING
Lynn Health Science Institute (LHSI), Oklahoma City
RECRUITING
Senior Adults Specialty Research, Austin
RECRUITING
Dent Neurosciences Research Center, Amherst
RECRUITING
Butler Hospital, Brown University, Providence
RECRUITING
Island Health Authorities, Victoria
RECRUITING
Hamilton Health Sciences , Mcmaster University, Hamilton
RECRUITING
Baycrest Academy, University of Toronto, Toronto
RECRUITING
Douglas Hospital Research Center, McGill university, Montreal
ACTIVE_NOT_RECRUITING
Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellín
COMPLETED
Instituto Sanacoop, Bayamón
RECRUITING
SCB Research Center, Bayamón
RECRUITING
University of Puerto Rico, Rio Piedras
Lead Sponsor
IGC Pharma, LLC
INDUSTRY